Christiane Reitz, MD, PhD Linkedin Dr. Reitz’s research focuses on the identification of genetic and non-genetic factors that contribute to Alzheimer’s disease, frontotemporal lobar degeneration, and structural and functional brain changes. She has been involved in a number of gene mapping and genetic epidemiology projects as well as non-genetic population-based studies that explore Alzheimer’s disease, vascular […]
Melissa Murray, PhD Linkedin Twitter Google I still recall the day I received the invitation to participate in the 2nd annual CCAD. The invitation came with the intriguing opportunity to propose an “out of the box” Alzheimer-centric project. As a translational neuropathologist whose research focus is on atypical AD, “out of the box” could be
Erik Musiek, MD, PhD Linkedin Twitter Facebook Google Previous Training: BS, College of William & Mary; MD, PhD, Vanderbilt Univ. School of Medicine; Residency in Neurology, Hospital of the Univ. of Pennsylvania (UPENN), Dementia Fellowship; Washington Univ. School of Medicine. In addition to my basic research, I see patients in the Memory Diagnostic Center and
Francesca Bartolini, PhD Linkedin Twitter Facebook Google Dr. Bartolini is a cell biologist with a Ph.D. in Biochemistry from NYU. Her research laboratory investigates the role of microtubule dynamics and tubulin post-translational modifications in neuronal physiology and at the onset of neurodegenerative and neuropathic disease. Her laboratory is located in the Dept. of Pathology &
Francesca Bartolini Read More »
Nicholas Fitz, PhD Linkedin Utilizing a multi-targeted approach my main research goal is to increase the understanding of how changes in gene function and apolipoprotein expression alters Alzheimer’s disease progression. During my graduate and post-doctoral training I received a broad training in utilizing animal models of neurodegenerative disease to test changes in cognition and biological
John Fryer, PhD Linkedin Twitter Google Dr. Fryer received his BS in microbiology at the University of Arizona before joining the lab of Dr. David Hotlzman, MD, at Washington University in St. Louis. There he studied mechanisms of amyloid formation in parenchyma and cerebral vessels in mouse models. After completing his Ph.D. in 2005, he
